Entero Healthcare Solutions Ltd. Stock Analysis ENTERO.NS

Entero Healthcare Solutions Ltd. engages in the provision of healthcare products and services. The company is headquartered in Mumbai, Maharashtra and currently employs 4,111 full-time employees. The company went IPO on 2024-02-16. The company offers a range of pharmaceuticals and other healthcare products to approximately 86,200 retail pharmacies and healthcare practitioners (HCPs) across 492 districts in India. Its portfolio includes over 68,900 SKUs from more than 2000 pharma companies. The firm is a supplier to over 3,500 hospitals across India, including corporate hospital chains. The company has over a network of 104 warehouses. Its technology solutions include Entero Direct, Entero CRM, Entero ERP, and Teqtic. Its Entero Direct platform is a cloud-based software-as-a-service solution that allows retailers to order their procurement needs. The Entero CRM application is a customer relationship management tool that manages and analyzes its interactions with customers, in order to customer retention and wallet share. The company also offers its products through the Aayu Chemist app and Medcords platform.